...
机译:用Toll样受体3配体预敏化会损害CD8 T细胞效应子分化和IL-33反应性
Department of Immunology, University of Connecticut Health Center, Farmington, CT 06030;
Department of Immunology, University of Connecticut Health Center, Farmington, CT 06030;
Department of Immunology, University of Connecticut Health Center, Farmington, CT 06030;
Inflammation Research, Amgen, Seattle, WA 98119;
Laboratory of Viral Oncology, Laboratory of Biotechnology and Applied Pharmacology, Ecole Normale Superieure de Cachan, 94235 Cachan Cedex, France;
Department of Immunology, University of Connecticut Health Center, Farmington, CT 06030;
Department of Immunology, University of Connecticut Health Center, Farmington, CT 06030;
superantigens; pathogen associated molecular patterns;
机译:腺病毒疫苗可以破坏CD8 + T细胞的耐受性,而Toll样受体配体的额外共同给药可以破坏CD4 + T细胞的耐受性。
机译:当Toll样受体和T细胞受体信号发生冲突时:CD8 T细胞效应子功能增强的机制。
机译:软骨细胞固有免疫髓系分化因子88依赖性信号驱动内源性Toll样受体2 / Toll样受体4配体的低分子量透明质酸和高迁移率组盒染色体蛋白1的促代谢作用
机译:病毒性损伤受体配体对卫生假设的实验方法的免疫调节作用
机译:Toll样受体配体激活的树突状细胞对人CD4 + T细胞反应的影响。
机译:用Toll样受体3配体预敏化会损害CD8 T细胞效应子分化和IL-33反应性
机译:用Toll样受体3配体抑制CD8 T细胞效应分化和IL-33反应性
机译:未成熟CD4 + CD8 +胸腺细胞中的配体刺激信号事件表达感受态T细胞受体复合物